Portable home hemodialysis
Topfer L-A
Record ID 32005000162
English, French
Authors' objectives:
The aim of this study is to summarize the available information on portable home hemodialysis devices: Home Dialysis Plus (HD+), Home Dialysis Plus Ltd., Portland OR; PHD Personal Hemodialysis System, Aksys Ltd., Lincolnshire, IL.
Authors' recommendations:
Daily nocturnal home hemodialysis involves more frequent and longer-duration hemodialysis. Advantages include improved patient well-being (better appetite and diet, less dietary restriction, less fatigue, shorter recovery time); better hemodynamic stability and blood pressure control; improved clearance of wastes. The US National Institutes of Health is funding a randomized controlled trial to compare conventional hemodialysis to short daily, and daily nocturnal home hemodialysis. Results should be available in 2008.
The HD+ device is at the prototype stage so there are no data on its clinical performance. The company is planning a trial involving 25 patients to support their application for US FDA premarket approval.
Authors' methods:
Overview
Details
Project Status:
Completed
URL for project:
https://www.ccohta.ca/
Year Published:
2005
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Renal Dialysis
Contact
Organisation Name:
Canadian Coordinating Office for Health Technology Assessment
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Coordinating Office for Health Technology Assessment (CCOHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.